These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35889343)

  • 21. Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box-Behnken Experimental Design.
    Soliman NM; Shakeel F; Haq N; Alanazi FK; Alshehri S; Bayomi M; Alenazi ASM; Alsarra IA
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules.
    Alhamhoom Y; Ravi G; Osmani RAM; Hani U; Prakash GM
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364338
    [No Abstract]   [Full Text] [Related]  

  • 23. Chitosan Nanoparticles for Enhanced Delivery of
    Alam P; Imran M; Ahmed S; Majid H; Akhtar A
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and Optimization of Avanafil Biodegradable Polymeric Nanoparticles: A Single-Dose Clinical Pharmacokinetic Evaluation.
    Aldawsari HM; Fahmy UA; Abd-Allah F; Ahmed OAA
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32604853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes.
    Thondawada M; Wadhwani AD; S Palanisamy D; Rathore HS; Gupta RC; Chintamaneni PK; Samanta MK; Dubala A; Varma S; Krishnamurthy PT; Gowthamarajan K
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1120-1129. PubMed ID: 29430979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical modeling of zaltoprofen loaded biopolymeric nanoparticles: Characterization and anti-inflammatory activity of nanoparticles loaded gel.
    Shah HA; Patel RP
    Int J Pharm Investig; 2015; 5(1):20-7. PubMed ID: 25599029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation design, optimization and
    Hasija R; Chaurasia S; Gupta S
    Pharm Dev Technol; 2021 Nov; 26(9):953-966. PubMed ID: 34374616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.
    Wang F; Yang S; Yuan J; Gao Q; Huang C
    J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
    Devarajan PV; Sonavane GS
    Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement.
    Mandpe L; Pokharkar V
    Pharm Dev Technol; 2015 May; 20(3):320-9. PubMed ID: 24328553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment.
    Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV
    Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and design optimization of nano-transferosomes using pioglitazone and eprosartan mesylate for concomitant therapy against diabetes and hypertension.
    Ramkanth S; Anitha P; Gayathri R; Mohan S; Babu D
    Eur J Pharm Sci; 2021 Jul; 162():105811. PubMed ID: 33757828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QbD-based Formulation Optimization and Characterization of Polymeric Nanoparticles of Cinacalcet Hydrochloride with Improved Biopharmaceutical Attributes.
    Ghose D; Patra CN; Ravi Kumar BVV; Swain S; Jena BR; Choudhury P; Shree D
    Turk J Pharm Sci; 2021 Sep; 18(4):452-464. PubMed ID: 34496552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
    Gajra B; Patel RR; Dalwadi C
    Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phytosterol-Loaded Surface-Tailored Bioactive-Polymer Nanoparticles for Cancer Treatment: Optimization, In Vitro Cell Viability, Antioxidant Activity, and Stability Studies.
    Karim S; Akhter MH; Burzangi AS; Alkreathy H; Alharthy B; Kotta S; Md S; Rashid MA; Afzal O; Altamimi ASA; Khalilullah H
    Gels; 2022 Apr; 8(4):. PubMed ID: 35448120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and evaluation of butenafine loaded PLGA-nanoparticulate laden chitosan nano gel.
    Alshehri S; Imam SS
    Drug Deliv; 2021 Dec; 28(1):2348-2360. PubMed ID: 34747275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catechol-Functionalized Alginate Nanoparticles as Mucoadhesive Carriers for Intravesical Chemotherapy.
    Sahatsapan N; Ngawhirunpat T; Rojanarata T; Opanasopit P; Patrojanasophon P
    AAPS PharmSciTech; 2020 Jul; 21(6):212. PubMed ID: 32737610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments.
    Rahat I; Imam SS; Rizwanullah M; Alshehri S; Asif M; Kala C; Taleuzzaman M
    Drug Deliv; 2021 Dec; 28(1):973-984. PubMed ID: 34036860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.